The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.
Clinical trial NCT05975554 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05975554
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-26
- Primary completion
- 2025-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.